Supply and Delivery of Live Attenuated Influenza Vaccine (LAIV) 2026/2027 Flu Season
TED · 674742-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Health Service Executive (HSE) in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JED Pharma LTD | 3 | €700,000 | 2026-08-27 |
| Celltrion Healthcare Ireland Limited. | 2 | €1,800,000 | 2026-08-27 |
| Roche Diagnostics Limited | 1 | €40,000,000 | 2026-09-18 |
| Nutricia Ireland Limited | Healthcare 21 | 1 | €34,000,000 | 2026-08-20 |
| Medray Imaging Systems Ltd | Trasmore Limited T/A Dental Medical Ireland | 1 | €9,189,000 | 2026-08-21 |
Full buyer profile: what Health Service Executive (HSE) buys and who wins it →
CPV codes
33651600 Medical equipment & pharmaceuticalsDescription
In accordance with the National Immunisation Advisory Committee Immunisation Guidelines of Ireland a National Contract for the Supply of Live Attenuated Influenza Vaccines (LAIV) to the HSE is required to vaccinate relevant cohorts and provide protection against Influenza. This contract will provide sufficient stock of LAIV to vaccinate relevant cohorts for the next 12 months. There is only one sole supplier of Live Attenuated Influenza Vaccines (LAIV) in Ireland.